Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for China Jo-Jo Drugstores Holdings Inc. (CJJD:NASDAQ), powered by AI.
China Jo-Jo Drugstores Holdings Inc. is currently trading at $1.38. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for China Jo-Jo Drugstores Holdings Inc. on Alpha Lenz.
China Jo-Jo Drugstores Holdings Inc.'s P/E ratio is -0.5.
“China Jo-Jo Drugstores Holdings Inc. trades at a P/E of -0.5 (undervalued) with modest ROE of -25.2%.”
Ask for details →China Jo-Jo Drugstores Holdings Inc. operates as a premier retail pharmacy chain in China, specializing in the distribution and sale of pharmaceutical products, health supplements, and personal care items. The company's core mission is to provide accessible and affordable healthcare solutions to the general public. It delivers services through an extensive network of physical retail locations and an online platform, facilitating consumer access to over-the-counter medicines and a variety of wellness products. China Jo-Jo Drugstores is notably involved in the healthcare and consumer goods sectors, directly impacting the pharmaceutical supply chain and retail convenience. It plays a crucial role in enhancing regional healthcare penetration by bridging the gap between consumers and healthcare essentials in both urban and rural areas. Established with a focus on quality and reliability, the company has positioned itself as a trusted name in China's growing healthcare market, contributing to the improvement of public health standards and supporting the nation’s healthcare infrastructure.
“China Jo-Jo Drugstores Holdings Inc. trades at a P/E of -0.5 (undervalued) with modest ROE of -25.2%.”
Ask for details →China Jo-Jo Drugstores Holdings Inc. (ticker: CJJD) is a company listed on NASDAQ in the Healthcare sector (Pharmaceutical Retailers). It has approximately 939 employees. Market cap is $2M.
The current price is $1.38 with a P/E ratio of -0.47x and P/B of 0.13x.
ROE is -25.16% and operating margin is -2.29%. Annual revenue is $155M.